Ziconotide for the treatment of severe spasticity after spinal cord injury

Pain

Volumn 85, Issue 1-2, 2000, Pages 287-289

  Ridgeway, Beri ^a   Wallace, Mark ^a   Gerayli, Afshin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Spasticity; Spinal cord injury; Treatment; Ziconotide

Indexed keywords

BACLOFEN; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; DANTROLENE; DIAZEPAM; MORPHINE; OMEGA CONOTOXIN MVIIA;

ADULT; ARTICLE; CASE REPORT; CONFUSION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HUMAN; NAUSEA; PARAPLEGIA; PRIORITY JOURNAL; QUADRIPLEGIA; SPASTICITY; SPINAL CORD INJURY;

ADULT; ANALGESICS, OPIOID; BACLOFEN; CALCIUM CHANNEL BLOCKERS; DRUG RESISTANCE; HUMANS; MALE; MORPHINE; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; OMEGA-CONOTOXINS; PARAPLEGIA; QUADRIPLEGIA; SPINAL CORD INJURIES;

EID: 0033955464     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00255-9     Document Type: Article

References (20)

1. Aosaki T., Kasai H. Characterization of two kinds of high-voltage-activated Ca-channel currents in chick sensory neurons. Differential sensitivity to dihydropyridines and omega-conotoxin GVIA. Pfugers Arch. 414:1989;150-156.
2. Apple D.F. Spinal cord injury rehabilitation. Herkowitz H.N., Garfin S.R., Balderston R.A., Eismont F.J., Bell G.R., Wiesel S.W. The spine. 1999;1125-1142 W.B. Saunders, Philadelphia.
3. Augustine G.J., Charlton M.P., Smith S.J. Calcium action in synaptic transmitter release. Annu Rev Neurosci. 10:1987;633-693.
4. Bean B.P. Classes of calcium channels in vertebrate cells. Annu Rev Physiol. 51:1989;367-384.
5. Bowersox S.S., Gadbois T., Singh T., Pettus M., Wang Y.X., Luther R.R. Selective N-type neuronal voltage-sensitive calcium channel blocker. SNX- 111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain. Journal of Pharmacol Exp Ther. 279:1996;1243-1249.
6. Chabal C., Jacobson L., Schwid H.A. An objective comparison of intrathecal lidocaine versus fentanyl for the treatment of lower extremity spasticity. Anesthesiology. 74:1991;643-646.
7. Chabal C., Jacobson L., Terman G. Intrathecal fentanyl alleviates spasticity in the presence of tolerance to intrathecal baclofen. Anesthesiology. 76:1992;312-316.
8. Hess P. Calcium channels in vertebrate cells. Annu Rev Neurosci. 13:1990;337-356.
9. Loubser P.G., Sharkey P., Dimitrijevic M. Control of chronic spasticity following spinal cord injury using intrathecal morphine. Anesth Analg. 67:1988;S135.
10. Malmberg A.B., Yaksh T.L. Effect of continuous intrathecal infusion of omegaconopeptides. N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats. Pain. 60:1994;83-90.
11. Middleton J.W., Siddall P.J., Walker S., Molloy A.R., Rutkowski S.B. Intrathecal clonidine and baclofen in the management of spasticity and neuropathic pain following spinal cord injury: a case study. Arch Phys Med Rehab. 77:1996;824-826.
12. Olivera B.M., Gray W.R., Zeikus R., McIntosh J.M., Varga J., Rivier J., de Santos V., Cruz L.J. Peptide neurotoxins from fish-hunting cone snails. Science. 230:1985;1338-1343.
13. Parke B., Penn R.D., Savoy S.M., Corcos D. Functional outcome after delivery of intrathecal baclofen. Arch Phys Med Rehab. 70:1989;30-32.
14. Penn R.D., Kroin J.S. Continuous intrathecal baclofen for severe spasticity. Lancet. 2:1985;125-127.
15. Penn R.D., Kroin J.S. Long-term intrathecal baclofen for treatment of spasticity. J Neurosurg. 66:1987;181-185.
16. Penn R.D., Savoy S.M., Corcos D., Latash M., Gottlieb G., Park B., Kroin J.S. Intrathecal baclofen for severe spinal spasticity. N Engl J Med. 320:1989;1517-1521.
17. Scher E., Clementi F. Omega-conotoxin-sensitive voltage-operated calcium channels in vertebrate cells. Neuroscience. 42:1991;42301-42307.
18. Shefner J.M., Berman S.A., Sarkarati M., Young R.R. Recurrent inhibition is increased in patients with spinal cord injury. Neurology. 42:1992;2162-2168.
19. Swandulla D., Carbone E., Lux H.D. Do calcium channel classifications account for neuronal calcium channel diversity? Trends Neurosci. 14:1991;46-51.
20. Xiao W.H., Bennett G.J. Synthetic omega-conopeptides applied to the site of nerve injury suppress neuropathic pains in rats. J Pharmacol Exp Ther. 274:1995;666-672.